Literature DB >> 26171022

Expression of the estrogen receptor α, progesterone receptor and epidermal growth factor receptor in papillary thyroid carcinoma tissues.

Dan Chen1, Wenjing Qi1, Pengxin Zhang1, Hongwei Guan1, Lifen Wang2.   

Abstract

The present study aimed to determine the protein expression, in addition to the clinical value of the expression, of estrogen receptor α (ERα), progesterone receptor (PR) and epidermal growth factor receptor (EGFR) in papillary thyroid carcinoma (PTC). The expression of ERα, PR and EGFR was examined immunohistochemically on paraffin-embedded thyroid tissues obtained from 64 patients with PTC and 14 patients with nodular thyroid goiter (NTG). The expression level of ERα, PR and EGFR was found to be significantly elevated in the PTC tissues compared with the NTG tissues. In addition, the expression of ERα was found to be correlated with the size of PTC tumors. However, there was no significant difference between the expression levels of ERα, PR and EGFR in males and females with PTC. Thus, immunohistochemical evaluation of ERα, PR and EGFR expression in patients with PTC may aid in the prediction of the prognosis of patients with PTC.

Entities:  

Keywords:  epidermal growth factor receptor; estrogen receptor α; papillary thyroid carcinoma; progesterone receptor

Year:  2015        PMID: 26171022      PMCID: PMC4487165          DOI: 10.3892/ol.2015.3223

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

Review 1.  Estrogen receptor beta in the prostate.

Authors:  Zhang Weihua; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Cell Endocrinol       Date:  2002-07-31       Impact factor: 4.102

Review 2.  Estrogen activity as a preventive and therapeutic target in thyroid cancer.

Authors:  Shilpi Rajoria; Robert Suriano; Andrea L George; Arulkumaran Shanmugam; Casey Jussim; Edward J Shin; Augustine L Moscatello; Jan Geliebter; Angelo Carpi; Raj K Tiwari
Journal:  Biomed Pharmacother       Date:  2011-12-28       Impact factor: 6.529

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues.

Authors:  Y Mizukami; A Nonomura; T Hashimoto; T Michigishi; M Noguchi; F Matsubara; N Yanaihara
Journal:  Histopathology       Date:  1991-01       Impact factor: 5.087

Review 5.  Thyroid cancer gender disparity.

Authors:  Reza Rahbari; Lisa Zhang; Electron Kebebew
Journal:  Future Oncol       Date:  2010-11       Impact factor: 3.404

6.  Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg Oncol       Date:  2006-11-11       Impact factor: 5.344

7.  Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.

Authors:  Briseis A Kilfoy; Susan S Devesa; Mary H Ward; Yawei Zhang; Philip S Rosenberg; Theodore R Holford; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

Review 8.  Embryonic estrogen receptors: do they have a physiological function?

Authors:  J Gorski; Q Hou
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

9.  Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

Authors:  L A Akslen; A O Myking; H Salvesen; J E Varhaug
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

10.  Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor α and β.

Authors:  Wenwu Dong; Hao Zhang; Jing Li; Haixia Guan; Liang He; Zhihong Wang; Zhongyan Shan; Weiping Teng
Journal:  Int J Endocrinol       Date:  2013-10-10       Impact factor: 3.257

View more
  14 in total

1.  Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.

Authors:  Wen-Wu Dong; Jian Li; Jing Li; Ping Zhang; Zhi-Hong Wang; Wei Sun; Hao Zhang
Journal:  Int J Exp Pathol       Date:  2018-04-14       Impact factor: 1.925

Review 2.  Mechanism Study on Chinese Medicine in Treatment of Nodular Goiter.

Authors:  Chang-Lin Wang; Ming-Zhou Gao; Xiang-Ju Gao; Xiang-Yu Mu; Jie-Qiong Wang; Dong-Mei Gao; Ming-Qi Qiao
Journal:  Chin J Integr Med       Date:  2022-08-31       Impact factor: 2.626

3.  Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.

Authors:  Mehdi Hedayati; Sadegh Rajabi; Abdolrahim Nikzamir
Journal:  Galen Med J       Date:  2020-05-21

4.  Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma.

Authors:  Marwa Mohammed Serag Eldien; Asmaa Gaber Abdou; Tarek Rageh; Eman Abdelrazek; Enas Elkholy
Journal:  Ecancermedicalscience       Date:  2017-06-13

5.  Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor.

Authors:  Yu Liu; Yanan Liang; Ming Li; Duanyang Liu; Jing Tang; Weiwei Yang; Dandan Tong; Xiaoming Jin
Journal:  Oncol Lett       Date:  2018-07-24       Impact factor: 2.967

6.  Distribution and Prognostic Significance of Estrogen Receptor α (ERα), Estrogen Receptor β (ERβ), and Human Epidermal Growth Factor Receptor 2 (HER-2) in Thyroid Carcinoma.

Authors:  Anjali Mishra; Niraj Kumari; Chandan Kumar Jha; Raouef Ahamed Bichoo; Shravan Kumar Mishra; Narendra Krishnani; Saroj Kanta Mishra
Journal:  J Thyroid Res       Date:  2020-05-05

Review 7.  Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.

Authors:  Ana Božović; Vesna Mandušić; Lidija Todorović; Milena Krajnović
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

8.  Low dose of Bisphenol A enhance the susceptibility of thyroid carcinoma stimulated by DHPN and iodine excess in F344 rats.

Authors:  Jing Zhang; Xiaochen Zhang; Yanan Li; Zhenzhen Zhou; Chuanlong Wu; Zhiyan Liu; Lanxiang Hao; Shanshan Fan; Fang Jiang; Yan Xie; Ling Jiang
Journal:  Oncotarget       Date:  2017-07-22

9.  Production of amphiregulin and recovery from influenza is greater in males than females.

Authors:  Meghan S Vermillion; Rebecca L Ursin; Denise I T Kuok; Landon G Vom Steeg; Nicholas Wohlgemuth; Olivia J Hall; Ashley L Fink; Eric Sasse; Andrew Nelson; Roland Ndeh; Sharon McGrath-Morrow; Wayne Mitzner; Michael C W Chan; Andrew Pekosz; Sabra L Klein
Journal:  Biol Sex Differ       Date:  2018-07-17       Impact factor: 5.027

10.  A Novel Combination of Metachronous Primary Malignancies of the Thyroid and Breast in a Patient with Neurofibromatosis Type 1.

Authors:  Dawood Findakly; Anup Solsi; Waqas Arslan
Journal:  Cureus       Date:  2020-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.